Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omnicell (OMCL) Cash & Equivalents (2016 - 2025)

Omnicell (OMCL) has disclosed Cash & Equivalents for 16 consecutive years, with $196.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 46.78% to $196.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $196.5 million through Dec 2025, down 46.78% year-over-year, with the annual reading at $196.5 million for FY2025, 46.78% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $196.5 million at Omnicell, up from $131.1 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $614.2 million in Q2 2021, with the low at $131.1 million in Q3 2025.
  • Average Cash & Equivalents over 5 years is $391.6 million, with a median of $384.1 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents skyrocketed 426.57% in 2021, then plummeted 77.03% in 2025.
  • Over 5 years, Cash & Equivalents stood at $349.1 million in 2021, then decreased by 5.35% to $330.4 million in 2022, then soared by 41.65% to $468.0 million in 2023, then dropped by 21.11% to $369.2 million in 2024, then tumbled by 46.78% to $196.5 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $196.5 million, $131.1 million, and $399.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.